Search

everythinglearnresearchcommunity

for

Search:↓

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Permanent hair dye may cause total hair loss.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.